Adriazola Semino 1992 |
Wrong study design/comparison: Serenoa repens vs active control (Prazosin). No indication of randomization |
Al‐Shukri 2000 |
Wrong study design: non‐randomized study |
Alcaraz 2022 |
Wrong study design: observational study |
Ali 2020 |
Wrong comparison: Serenoa repens vs alpha‐blockers |
Aliaev 2009 |
Wrong study population: men had chronic abacterial prostatitis |
Authié 1987 |
Wrong study design: non‐randomized study |
Bartsch 1998 |
Wrong comparison: Serenoa repens vs finasteride |
Braeckman 1997 |
Wrong comparison: different doses of Serenoa repens
|
Cai 2013 |
Wrong comparison: IDIProst vs Serenoa repens
|
Carraro 1996 |
Wrong comparison: Serenoa repens vs finasteride |
Comar 1986 |
Comparison with mepartricin |
CTRI/2012/10/003049 |
Wrong comparison: different doses of phytotherapy |
CTRI/2020/09/027521 |
Wrong comparison: Serenoa repens vs SAW‐1720 |
Debruyne 2002 |
Wrong comparison: with alpha‐blocker |
Di Maida 2020 |
Wrong study design: non‐randomized comparative study |
Di Silverio 1992 |
Tissue study investigating the antiestrogenic effect of Serenoa repens vs placebo |
Duborija‐Kovacevic 2010 |
Wrong comparison: Serenoa repens vs doxazosin and finasteride |
Engelmann 2006 |
Wrong comparison: Serenoa repens vs tamsulosin |
EUCTR2011‐005307‐33‐FR |
Wrong comparison: Serenoa repens vs tamsulosin |
Gerber 1998 |
Wrong study design: no control group |
Giannakopoulos 2002 |
Wrong study design: no control group |
Giulianelli 2012 |
Wrong study design: observational study |
Grasso 1995 |
Wrong comparison: Serenoa repens vs alpha‐blocker |
Gurzhenko 2020 |
Wrong study design: observational study |
Guzman 2016 |
Wrong comparison: D‐004 vs Serenoa repens
|
Hamdv 1997 |
Wrong comparison: Serenoa repens vs finasteride |
Ju 2015 |
Wrong study design: no comparison |
Latil 2015 |
Wrong comparison: Serenoa repens vs alpha‐blockers |
Morgia 2013 |
Wrong study population: men subject to histologic sampling |
Morgia 2018 |
Wrong comparison: Serenoa repens vs tadalafil |
NCT00797394 |
Wrong comparison: Serenoa repens as a co‐intervention |
Pannunzio 1986 |
Wrong comparison: Serenoa repens vs gestonorone caproate |
Pavone 2010 |
Wrong study design: not a randomized controlled trial |
Pecoraro 2004 |
Wrong population: study focused on the use of the drug as preoperative adjuvant treatment |
Popa 2005 |
Wrong study design: independent re‐analysis of the included study Metzker 1996
|
Romaniuk 2013 |
Wrong comparison: Serenoa repens vs doxazosin and finasteride |
Roveda 1994 |
Wrong comparison: Serenoa repens oral vs rectal route |
Sinescu 2011 |
Wrong study design: non‐randomized study |
Stepanov 1999 |
Wrong study design: no control group |
Strauch 1994 |
Wrong comparison: Serenoa repens vs finasteride |
Suardi 2014 |
Wrong patient population: men with prostatitis |
Sökeland 1997 |
Wrong comparison: Serenoa repens vs finasteride |
Taieb 2010 |
Wrong study design: observational study |
Vela‐Navarrete 2005 |
Study focused on tissue samples of the prostate. |
Veltri 2002 |
Wrong study population: study focused on prostatic tissue |
Vinarov 2010 |
Wrong study design: no active or placebo control |
Weisser 1997 |
Wrong study population: prostatic tissue (enzyme study) |
Yamanishi 2004 |
Wrong comparison: Serenoa repens vs alpha‐blockers |
Zlotta 2005 |
Wrong study design: re‐analysis of previous studies |